XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

0
Player Avatar Woopde (< 20) Submitted: 4/8/2011 1:21:56 AM : Outperform Start Price: $9.77 XNPT Score: -38.46

FDA

Report this Post 1 Comment
Member Avatar BuffettJunior1 (97.53) Submitted: 4/8/2011 4:17:46 PM
Recs: 0

Terrible fundamentals and an unpredictable business. Don't waste you money with this.

Featured Broker Partners


Advertisement